X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (190) 190
Publication (26) 26
Book / eBook (22) 22
Book Chapter (4) 4
Dissertation (3) 3
Conference Proceeding (2) 2
Newspaper Article (2) 2
Magazine Article (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (58) 58
index medicus (57) 57
female (37) 37
hematology (37) 37
oncology (35) 35
male (34) 34
middle aged (29) 29
aged (27) 27
transplantation (27) 27
adult (25) 25
chemotherapy (21) 21
lymphomas (21) 21
article (19) 19
rituximab (19) 19
treatment outcome (19) 19
care and treatment (16) 16
non-hodgkin lymphoma (16) 16
abridged index medicus (14) 14
antineoplastic combined chemotherapy protocols - therapeutic use (14) 14
cancer (14) 14
survival (14) 14
hematology, oncology and palliative medicine (13) 13
patients (13) 13
research (13) 13
therapy (13) 13
aged, 80 and over (12) 12
risk factors (12) 12
analysis (11) 11
cyclophosphamide (11) 11
disease-free survival (11) 11
outcomes (11) 11
recurrence (11) 11
hemic and lymphatic diseases (10) 10
b-cell lymphoma (9) 9
lymphoma (9) 9
mantle cell lymphoma (9) 9
prognosis (9) 9
stem cells (9) 9
autologous transplantation (8) 8
expression (8) 8
follow-up (8) 8
non-hodgkins-lymphoma (8) 8
progression-free survival (8) 8
relapse (8) 8
retrospective studies (8) 8
stem cell transplantation (8) 8
united states (8) 8
young adult (8) 8
antineoplastic agents - therapeutic use (7) 7
autografts (7) 7
diagnosis (7) 7
kaplan-meier estimate (7) 7
risk (7) 7
transplantation, autologous (7) 7
allogeneic transplantation (6) 6
bendamustine (6) 6
blood (6) 6
children (6) 6
follicular lymphoma (6) 6
follow-up studies (6) 6
health risk assessment (6) 6
hematopoietic stem cell transplantation (6) 6
high-dose therapy (6) 6
hodgkin lymphoma (6) 6
immune system diseases (6) 6
immunochemotherapy (6) 6
immunology (6) 6
immunotherapy (6) 6
international prognostic index (6) 6
patient outcomes (6) 6
usage (6) 6
antibodies, monoclonal, murine-derived - therapeutic use (5) 5
cardiac & cardiovascular systems (5) 5
chop (5) 5
clinical trials (5) 5
cohort studies (5) 5
combined modality therapy (5) 5
cyclophosphamide - therapeutic use (5) 5
electronic books (5) 5
health aspects (5) 5
hematopoietic stem cells (5) 5
lymphoma, large b-cell, diffuse - mortality (5) 5
lymphoma, large b-cell, diffuse - therapy (5) 5
lymphoma, mantle-cell - therapy (5) 5
lymphoma, non-hodgkin - drug therapy (5) 5
lymphoma, non-hodgkin - therapy (5) 5
medical research (5) 5
medicine (5) 5
medicine, general & internal (5) 5
multicenter (5) 5
multivariate analysis (5) 5
mutation (5) 5
neoplasm staging (5) 5
non-hodgkin-lymphoma (5) 5
non‐hodgkin lymphoma (5) 5
plus rituximab (5) 5
positron-emission-tomography (5) 5
prednisone (5) 5
rituximab - therapeutic use (5) 5
stenosis (5) 5
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (10) 10
Gerstein Science - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
UTL at Downsview - May be requested (4) 4
Law (Bora Laskin) - Stacks (3) 3
Trinity College (John W Graham) - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Criminology - Stacks (1) 1
Knox College (Caven) - Stacks (1) 1
OISE - Stacks (1) 1
Online Resources - Online (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
St. Michael's College (John M. Kelly) - Reference (1) 1
Trinity College (John W Graham) - Storage (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University E.J. Pratt - Reference (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 10/2017, Volume 130, Issue 17, pp. 1876 - 1877
In this issue of Blood, Eskelund et al identify a high-risk group of patients with mantle cell lymphoma (MCL) who do not experience prolonged survival despite... 
SURVIVAL | MANTLE-CELL LYMPHOMA | HEMATOLOGY | LANDSCAPE | PROGNOSTIC VALUE | DELETION
Journal Article
Hematology. American Society of Hematology. Education Program, ISSN 1520-4391, 11/2018, Volume 2018, Issue 1, pp. 75 - 82
Journal Article
Blood, ISSN 0006-4971, 09/2019
Key Points Umbralisib plus ublituximab exhibited low rates of immune-mediated toxicities associated with other PI3K-δ inhibitors. This combination had... 
Journal Article
CANCER, ISSN 0008-543X, 11/2017, Volume 123, Issue 22, pp. 4411 - 4418
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2978 - 2978
Abstract Introduction: Previously, we reported that CD30 expression was not acquired at time of relapse in patients with diffuse large B-cell lymphoma (DLBCL)... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4197 - 4197
Abstract Introduction: Umbralisib (UMB) is a next generation, once daily, PI3Kδ/CK1ε inhibitor, active in patients with relapsed or refractory (rel/ref)... 
Journal Article
Oncology (Williston Park, N.Y.), ISSN 0890-9091, 11/2017, Volume 31, Issue 11, pp. 821 - 828
The phosphatidylinositol 3-kinase (PI3K) pathway has attracted immense interest as a therapeutic target for cancer treatment. Idelalisib was the first PI3K... 
INSULIN | P110-DELTA | PRESSURE | P110-ALPHA | ONCOLOGY | IDELALISIB | RITUXIMAB | KINASE | AKT | PHOSPHOINOSITIDE 3-KINASE | ASSOCIATION | Enzyme Inhibitors - adverse effects | Purines - adverse effects | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Antineoplastic Agents - adverse effects | Humans | Quinazolinones - adverse effects
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2966 - 2966
Abstract Background: Recent regulatory approvals of two CD19-targeted chimeric antigen receptor (CAR)-expressing autologous T lymphocyte therapies provide... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4225 - 4225
Abstract Introduction: Prior series have identified CD30 expression by immunohistochemistry (IHC) is associated with improved overall survival (OS) in patients... 
Journal Article
Journal Article
by Gerson, James N and Handorf, Elizabeth and Villa, Diego and Villa, Diego and Gerrie, Alina S and Gerrie, Alina S and Chapani, Parv and Chapani, Parv and Li, Shaoying and Jeffrey Medeiros, L and Medeiros, L Jeffrey and Wang, Michael I and Wang, Michael I and Cohen, Jonathon B and Calzada, Oscar and Churnetski, Michael C and Churnetski, Michael C and Hill, Brian T and Hill, Brian T and Sawalha, Yazeed and Hernandez-Ilizaliturri, Francisco J and Hernandez-Ilizaliturri, Francisco J and Kothari, Shalin and Kothari, Shalin and Vose, Julie M and Vose, Julie M and Bast, Martin A and Fenske, Timothy S and Narayana Rao Gari, Swapna and Gari, Swapna Narayana Rao and Maddocks, Kami J and Maddocks, Kami J and Bond, David and Bond, David and Bachanova, Veronika and Bachanova, Veronika and Kolla, Bhaskar and Kolla, Bhaskar and Chavez, Julio and Chavez, Julio and Shah, Bijal and Shah, Bijal and Lansigan, Frederick and Lansigan, Frederick and Burns, Timothy F and Burns, Timothy F and Donovan, Alexandra M and Donovan, Alexandra M and Wagner-Johnston, Nina and Wagner-Johnston, Nina and Messmer, Marcus and Messmer, Marcus and Mehta, Amitkumar and Mehta, Amitkumar and Anderson, Jennifer K and Anderson, Jennifer K and Reddy, Nishitha and Reddy, Nishitha and Kovach, Alexandra E and Kovach, Alexandra E and Landsburg, Daniel J and Landsburg, Daniel J and Glenn, Martha and Glenn, Martha and Inwards, David J and Inwards, David J and Karmali, Reem and Karmali, Reem and Kaplan, Jason B and Kaplan, Jason B and Caimi, Paolo F and Caimi, Paolo F and Rajguru, Saurabh and Rajguru, Saurabh and Evens, Andrew and Evens, Andrew and Klein, Andreas and Klein, Andreas and Umyarova, Elvira and Umyarova, Elvira and Pulluri, Bhargavi and Pulluri, Bhargavi and Amengual, Jennifer E and Amengual, Jennifer E and Lue, Jennifer K and Lue, Jennifer K and Diefenbach, Catherine and Diefenbach, Catherine and Fisher, Richard I and Fisher, Richard I and Barta, Stefan K
Journal of Clinical Oncology, ISSN 0732-183X, 2019, Volume 37, Issue 6, pp. 471 - 480
PURPOSEMantle cell lymphoma (MCL) is a B-cell lymphoma characterized by cyclin D1 expression. Autologous hematopoietic cell transplantation (AHCT)... 
PATHOGENESIS | IMMUNOCHEMOTHERAPY | MULTICENTER | IMPACT | THERAPY | RANDOMIZED-TRIALS | PATTERN | ONCOLOGY | INTERNATIONAL PROGNOSTIC INDEX | PROGRESSION-FREE SURVIVAL | TRANSPLANTATION
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 5114 - 5114
Introduction: BKM120 is a potent and highly specific oral pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor. Several PI3K inhibitors have single agent... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4216 - 4216
Abstract Introduction Axicabtagene citoleucel (axi-cel) is a recently approved, highly effective treatment for relapsed and refractory aggressive B cell... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Suppl_1, pp. 4848 - 4848
Abstract Introduction: Chronic lymphocytic leukemia (CLL) is a common leukemia which tends to occur late in life. Comorbidities are common, and the iwCLL... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1776 - 1776
Abstract Background: Buparlisib is a potent and highly specific oral pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor. Several PI3K inhibitors have... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.